Table of Contents
Washington University Experience | NEOPLASMS (HEMATOLYMPHOID) | Langerhans Cell Histiocytosis (LCH) | 24F2 LCH (Case 24) BRAF 20X 3
The immunohistochemical profile also includes immunoreactivity for mutant BRAF (BRAF V600E IHC).
